2023
Press Releases
-
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
-
Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award
-
Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research
-
Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases
-
New Study Shows Allergic Asthma Provides Intrinsic Protection Against Severe COVID-19
-
COVID-19 mRNA Vaccination Does Not Promote Autoantibody Development
-
New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells
-
New Study from Benaroya Research Institute and the University of Washington Identify Novel Mechanism of Regulatory T Cells’ Role in Maintaining Immune System Homeostasis
-
New Study from Benaroya Research Institute Identifies Mechanisms for How Two Air Pollutants Exacerbate Asthma in Urban Children
2022
Press Releases
-
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
-
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
-
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
-
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
-
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
-
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award
Benaroya Research Institute Immunologist John Ray Receives 2023 NIH Director’s New Innovator Award
Benaroya Research Institute Receives $9 Million in Funding, With a Focus on Down Syndrome Research
Benaroya Research Institute Awarded $3.1 Million National Institutes of Health Grant to Study the Inflammatory Cycle of Common Skin Diseases
New Study Shows Allergic Asthma Provides Intrinsic Protection Against Severe COVID-19
COVID-19 mRNA Vaccination Does Not Promote Autoantibody Development
New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells
New Study from Benaroya Research Institute and the University of Washington Identify Novel Mechanism of Regulatory T Cells’ Role in Maintaining Immune System Homeostasis
New Study from Benaroya Research Institute Identifies Mechanisms for How Two Air Pollutants Exacerbate Asthma in Urban Children
-
Benaroya Research Institute Awarded $3.4 Million NIH R01 Grant to Continue Studying Why Immune Responses Are Altered in those with Down Syndrome
-
New Type 1 Diabetes Research Breakthrough: Development of Engineered T Cells as Potential Treatment
-
New Asthma Treatment Shows Promise and Future Directions for Disproportionately Affected Kids
-
Benaroya Research Institute Team Discovers T cell Based Biomarker and Potential Therapeutic Target for Colon Cancer
-
BRI Advances Understanding of the Link Between Genetics and Autoimmune Disease Risk
-
Benaroya Research Institute Awarded $11.4M NIH U19 Grant to Profile Respiratory Viral Infections in Vulnerable Populations and $3.9M NIH R01 Grant to Develop New Treatments for Type 1 Diabetes
